Belpointe Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-418
| Closed | -$4.33K | – | 1326 |
|
|
2023
Q1 | $4.33K | Sell |
418
-75
| -15% | -$777 | ﹤0.01% | 3069 |
|
|
2022
Q4 | $5.82K | Buy |
+493
| New | +$5.82K | ﹤0.01% | 2872 |
|
|
2021
Q4 | – | Sell |
-3,413
| Closed | -$161K | – | 1215 |
|
|
2021
Q3 | $161K | Buy |
3,413
+1,307
| +62% | +$61.7K | 0.01% | 949 |
|
|
2021
Q2 | $122K | Buy |
+2,106
| New | +$122K | 0.01% | 1040 |
|